Clinical TrialsSearch results
Number of results: 891
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Completed
- A Phase 1 Study of S-770108 in Patients with Idiopathic Pulmonary Fibrosis
- Idiopathic pulmonary fibrosis
- Nagata Tsutae
- 2022-01-17
Other
- A Phase 1/2/3 Study of S-268019 in Participants Aged 5 to 11 Years (Part 2)(COVID-19)
- Prevention of COVID-19
- Gomez Juan Carlos
- 2022-12-08
Other
- A phase 2 multicenter clinical study evaluating the safety and efficacy of Nilotinib in patients with Imatinib- resistant/intolerant CML in chronic phase
- Chronic myelogenous leukemia
- Tokyo STI Study Group
- 2009-05-01
Other
- A phase 2 multicenter study evaluating the safety and efficacy of Nilotinib in patients with Imatinib-resistant/intolerant Ph+CML in chronic phase
- Chronic myelogenous leukemia
- Shimousa Hematology Study Group
- 2009-06-01
Other
- A phase 2 neoadjuvant chemotherapy of Irinotecan (CPT-11) plus Nedaplatin (NDP) for stage 1b2 or 2 cervical cancer of the uterine cervix
- stage 1b2/2 cervical cancer
- Japanese Gynecologic Oncology Group
- 2006-12-21
Recruiting
- A Phase 2 Study to Assess the Efficacy and Safety of KHK4951 in Patients with Diabetic Macular Edema
- Diabetic Macular Edema (DME)
- Takigawa Sotaro
- 2023-10-16
Recruiting
- A Phase 2 Study to Assess the Efficacy and Safety of KHK4951 in Patients with Neovascular Age-Related Macular Degeneration
- Neovascular Age-related Macular Degeneration (nAMD)
- Takigawa Sotaro
- 2023-10-16
Recruiting
- A Phase 2, Multicenter, Placebo-Controlled, Randomized, Double-Blind, 48-Week Study to Evaluate the Efficacy and Safety of Combination Therapy of K-877-ER and CSG452 in Patients with Noncirrhotic Nonalcoholic Steatohepatitis (NASH) with Liver Fibrosis
- NASH
- Tanigawa Ryohei
- 2023-04-29
Completed
- A Phase 2, Randomized, Double-Blind, does-finding, Parallel Group, Multi-Center Study to evaluate Efficacy and Safety of M118103 in Subjects with Prurigo nodularis.
- Prurigo nodularis
- Nishiura Tomoyuki
- 2021-04-09
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Metformin
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2009-04-01